Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-28

FDA Approved: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for fingolimod filed by XLCare Pharmaceuticals Inc., indicating regulatory approval of a change to the product (such…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GILENYA (FINGOLIMOD HCL)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)